Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esperanza Such

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Therapeutic Advances in Hematology|January 8, 2024
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromesJuan Carlos Caballero, Julio Dávila, María López-Pavía, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2015
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3Jose Maria Raya, Taida Martín-Santos, Elisa Luño, et al.
NPJ Precision Oncology|January 7, 2026
Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AMLNeus Torres-Hernández, Elvira Mora, Cristian García-Ruiz, et al.
British Journal of Haematology|July 23, 2021
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutationsIván Martín, Eva Villamón, Rosario Abellán, et al.
British Journal of Haematology|October 18, 2019
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemiaLaura Palomo, Mariam Ibáñez, María Abáigar, et al.
British Journal of Haematology|April 11, 2014
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletionJoaquín Sánchez-García, Consuelo Del Cañizo, Ignacio Lorenzo, et al.
Cancers|January 8, 2025
Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic LeukemiaJosgrey Navas-Acosta, Alberto Hernández-Sánchez, Teresa González, et al.
Scientific Reports|April 5, 2020
Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal KaryotypeMariam Ibáñez, Esperanza Such, Esther Onecha, et al.
The Journal of Molecular Diagnostics : JMD|February 1, 2026
Copy-Neutral Loss of Heterzygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism ArraysÁlvaro Díaz-González, Elvira Mora, Marta Garrote, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia PatientsMariam Ibáñez, Esperanza Such, Alessandro Liquori, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Hematology|January 8, 2024
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromesJuan Carlos Caballero, Julio Dávila, María López-Pavía, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2015
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3Jose Maria Raya, Taida Martín-Santos, Elisa Luño, et al.
NPJ Precision Oncology|January 7, 2026
Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AMLNeus Torres-Hernández, Elvira Mora, Cristian García-Ruiz, et al.
British Journal of Haematology|July 23, 2021
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutationsIván Martín, Eva Villamón, Rosario Abellán, et al.
British Journal of Haematology|October 18, 2019
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemiaLaura Palomo, Mariam Ibáñez, María Abáigar, et al.
British Journal of Haematology|April 11, 2014
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletionJoaquín Sánchez-García, Consuelo Del Cañizo, Ignacio Lorenzo, et al.
Cancers|January 8, 2025
Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic LeukemiaJosgrey Navas-Acosta, Alberto Hernández-Sánchez, Teresa González, et al.
Scientific Reports|April 5, 2020
Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal KaryotypeMariam Ibáñez, Esperanza Such, Esther Onecha, et al.
The Journal of Molecular Diagnostics : JMD|February 1, 2026
Copy-Neutral Loss of Heterzygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism ArraysÁlvaro Díaz-González, Elvira Mora, Marta Garrote, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia PatientsMariam Ibáñez, Esperanza Such, Alessandro Liquori, et al.
Pageof 9